Ticker Details
Amneal Pharmaceuticals, Inc.
IPO Date:	January 1, 1900
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.85%
Avg Daily Range (30 D):	$0.37 | 2.09%
Avg Daily Range (90 D):	$0.31 | 2.12%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	1.49M
Avg Daily Volume (90 D):	1.33M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	2,210
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$4.48M
Avg Institutional Trade (90 D):	$3.46M
Avg Institutional Trade Volume:	.21M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.55M
Avg Closing Trade (30 D):	$8.96M
Avg Closing Trade (90 D):	$6M
Avg Closing Volume:	250.06K

News

Jul 17, 2026 @ 12:00 PM Amneal Expands Iohexol Injection Portfolio with U.... Source: Not Specified

Jun 4, 2026 @ 5:00 PM IgE Receptor Antagonists Clinical Trial Pipeline A... Source: Delveinsight

Apr 22, 2026 @ 11:15 AM Why Is Amneal Pharmaceuticals Stock Gaining Today?... Source: Nabaparna Bhattacharya

Apr 14, 2026 @ 12:00 PM Amneal Launches First Two Respiratory Metered-Dose... Source: Not Specified

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.2	$.11	$.23
Diluted EPS	$.19	$.11	$.22
Revenue	$722.52M	$814.32M	$3.02B
Gross Profit	$320.11M	$297.19M	$1.11B
Net Income / Loss	$78M	$49.57M	$127.93M
Operating Income / Loss	$141.77M	$112.03M	$394.1M
Cost of Revenue	$402.41M	$517.13M	$1.91B
Net Cash Flow	$-108.53M	$74.53M	$194.52M
PE Ratio

Splits
Aug 26, 2013	1:25